When should active surveillance for prostate cancer stop if no progression is detected? - Wikidata - wikimedia - TriplyDB

When should active surveillance for prostate cancer stop if no progression is detected?

When should active surveillance for prostate cancer stop if no progression is detected?

http://www.wikidata.org/entity/Q38832126

about

Active surveillance: a review of risk-based, dynamic monitoring.

P2860

Q55265467-4901F0A7-E327-4255-967E-4A11DCCE9B1C

P2860

When should active surveillance for prostate cancer stop if no progression is detected?

http://www.wikidata.org/entity/Q38832126

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

When should active surveillance for prostate cancer stop if no progression is detected?

@en

type

label

When should active surveillance for prostate cancer stop if no progression is detected?

@en

prefLabel

When should active surveillance for prostate cancer stop if no progression is detected?

@en

P1433

Q38832126-2A1AB6C3-FAFA-4508-B97B-24CAE2FF3B61

P1476

Q38832126-36F7B3DA-4AF2-4ABB-BF6F-E3B6F70613E8

P2093

Q38832126-DC53B5B6-4886-46CE-9730-7701E4D65024

Q38832126-F1291156-70CD-48FA-8C7B-ACDC17B4881F

P2860

Q38832126-00993155-2F7D-4DCB-AD08-07EE2EAD639F

Q38832126-03287FDB-0C75-49D3-B4CE-C030B5F3A358

Q38832126-091CC6AB-5A1F-40C8-8990-0F05F68DDAB7

Q38832126-0C1DD09A-E811-4051-965A-1FB7B373CBFD

Q38832126-0D8749B5-3217-44C9-89F9-1FE28B7D1711

Q38832126-0F513D1C-0094-4D16-8BC0-C07778A6A0F8

Q38832126-1BE83C8C-762B-42E1-8A3C-787F292561B5

Q38832126-217428D8-AF18-47B4-8A1C-C75D93D7C138

Q38832126-26C87F23-48AA-4EF8-BAB4-1A3B78397634

Q38832126-40EFF3EA-5ABD-4F87-8AB2-34B4E774672F

P304

Q38832126-1E7A0823-0DD2-4C9B-B994-C9BA8F7C6EB5

P31

Q38832126-33CEC627-C8A7-43C1-B3BA-C52BC68769DF

P356

Q38832126-B0975AAB-C38E-4830-851F-CAEE4AAD700C

P433

Q38832126-3BCDEC3C-2B47-4ABF-8FBB-82506185E24E

P478

Q38832126-CE72F683-9A2F-4C77-83D2-884FE79629E4

P50

Q38832126-A042E3C3-0D8E-46B0-92DB-0BB437313843

P577

Q38832126-DBBC5B36-630A-46A4-A14A-089F6935C147

P698

Q38832126-7FA8ACFB-BEE9-44BC-8DD9-77AE6558F658

P356

P1433

P1476

When should active surveillance for prostate cancer stop if no progression is detected?

@en

P2093

Eveline A M Heijnsdijk

http://www.w3.org/2001/XMLSchema#string

Harry J de Koning

http://www.w3.org/2001/XMLSchema#string

P2860

The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer.

Radical prostatectomy or watchful waiting in early prostate cancer.

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Quality-of-life effects of prostate-specific antigen screening.

Outcomes of active surveillance for men with intermediate-risk prostate cancer.

The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines.

Prostate cancer mortality following active surveillance versus immediate radical prostatectomy.

Treatment of local-regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors

Active surveillance for prostate cancer compared with immediate treatment: an economic analysis

Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies

P304

962-969

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.23352

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P50

Tiago M de Carvalho

P577

2017-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28419541

http://www.w3.org/2001/XMLSchema#string